5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Hypercholesterolemia-induced increase in plasma oxidized LDL abrogated pro angiogenic response in kidney grafts

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Renal transplantation is increasingly associated with the presence of comorbidity factors such as dyslipidemia which could influence the graft outcome. We hypothesized that hypercholesterolemia could affect vascular repair processes and promote post-transplant renal vascular remodeling through the over-expression of the anti-angiogenic thrombospondin-1 interacting with vascular endothelial growth factor-A levels.

          Methods

          We tested this hypothesis in vitro, in vivo and in a human cohort using (1) endothelial cells; (2) kidney auto-transplanted pig subjected (n = 5) or not (n = 6) to a diet enriched in cholesterol and (3) a renal transplanted patient cohort (16 patients).

          Results

          Cells exposed to oxidized LDL showed reduced proliferation and an increased expression of thrombospondin-1. In pigs, 3 months after transplantation of kidney grafts, we observed a deregulation of the hypoxia inducible factor 1a—vascular endothelial growth factor-A axis induced in cholesterol-enriched diet animals concomitant with an overexpression of thrombospondin-1 and a decrease in cortical microvessel density promoting vascular remodeling. In patients, hypercholesterolemia was associated with decreased vascular endothelial growth factor-A plasma levels during early follow up after renal transplantation and increased chronic graft dysfunction.

          Conclusions

          These results support a potential mechanism through which a high fat-diet impedes vascular repair in kidney graft and suggest the value of controlling cholesterolemia in recipient even at the early stage of renal transplantation.

          Electronic supplementary material

          The online version of this article (10.1186/s12967-018-1764-4) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references35

          • Record: found
          • Abstract: found
          • Article: not found

          Requirement of vascular integrin alpha v beta 3 for angiogenesis.

          Angiogenesis depends on the adhesive interactions of vascular cells. The adhesion receptor integrin alpha v beta 3 was identified as a marker of angiogenic vascular tissue. Integrin alpha v beta 3 was expressed on blood vessels in human wound granulation tissue but not in normal skin, and it showed a fourfold increase in expression during angiogenesis on the chick chorioallantoic membrane. In the latter assay, a monoclonal antibody to alpha v beta 3 blocked angiogenesis induced by basic fibroblast growth factor, tumor necrosis factor-alpha, and human melanoma fragments but had no effect on preexisting vessels. These findings suggest that alpha v beta 3 may be a useful therapeutic target for diseases characterized by neovascularization.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The thrombospondins.

            Thrombospondin-1 (TSP-1) was studied in the 1980s as a major component of platelet alpha-granules released upon platelet activation and also as a cell adhesion molecule. In 1993, we published a short review that discussed the exciting identification by molecular cloning of four additional vertebrate gene products related to TSP-1 [Current Biology 3 (1993) 188]. We put forward a structurally based classification for the newly identified proteins and discussed the functional and evolutionary implications of the new gene family. Since that time, the depth and breadth of knowledge on vertebrate TSPs and their functions in cells and tissues in health and disease has expanded into important new areas. Of particular interest is the new knowledge on the complex, domain and cell-type specific effects of TSPs on cell-signaling and cell-adhesion behaviour, the roles of TSP-1 and TSP-2 as anti-angiogenic agents, the roles of TSP-1 and TSP-2 in wound-healing, and associations of point mutations and polymorphisms in TSP-1, TSP-4 and TSP-5/COMP with human genetic diseases. The TSP family also now includes invertebrate members. In this article, we give the 2004 view on TSPs and our perspectives on the significant challenges that remain. Other articles in this issue discuss the functions of vertebrate TSPs in depth.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Contribution of Large Pig for Renal Ischemia-Reperfusion and Transplantation Studies: The Preclinical Model

              Animal experimentation is necessary to characterize human diseases and design adequate therapeutic interventions. In renal transplantation research, the limited number of in vitro models involves a crucial role for in vivo models and particularly for the porcine model. Pig and human kidneys are anatomically similar (characterized by multilobular structure in contrast to rodent and dog kidneys unilobular). The human proximity of porcine physiology and immune systems provides a basic knowledge of graft recovery and inflammatory physiopathology through in vivo studies. In addition, pig large body size allows surgical procedures similar to humans, repeated collections of peripheral blood or renal biopsies making pigs ideal for medical training and for the assessment of preclinical technologies. However, its size is also its main drawback implying expensive housing. Nevertheless, pig models are relevant alternatives to primate models, offering promising perspectives with developments of transgenic modulation and marginal donor models facilitating data extrapolation to human conditions.
                Bookmark

                Author and article information

                Contributors
                thomas.kerforne@gmail.com
                frederic.favreau@unilim.fr
                kookwa963@gmail.com
                souleymane.maiga@gmail.com
                geraldineallain@yahoo.fr
                antoine.thierry@chu-poitiers.fr
                manuel.dierick@ugent.be
                edouardbaulier@yahoo.fr
                clara.steichen@gmail.com
                33 5 49 44 47 85 , thierry.hauet@gmail.com
                Journal
                J Transl Med
                J Transl Med
                Journal of Translational Medicine
                BioMed Central (London )
                1479-5876
                14 January 2019
                14 January 2019
                2019
                : 17
                : 26
                Affiliations
                [1 ]INSERM U1082 IRTOMIT, 2 rue de la Milétrie, CS90577, 86000 Poitiers, France
                [2 ]ISNI 0000 0000 9336 4276, GRID grid.411162.1, Service d’Anesthésie-Réanimation, , CHU de Poitiers, ; 86000 Poitiers, France
                [3 ]ISNI 0000 0001 2160 6368, GRID grid.11166.31, Faculté de Médecine et de Pharmacie, , Université de Poitiers, ; 86000 Poitiers, France
                [4 ]ISNI 0000 0001 2165 4861, GRID grid.9966.0, Faculté de Médecine, EA 6309 “Maintenance Myélinique et Neuropathies Périphériques», , Université de Limoges, ; 87000 Limoges, France
                [5 ]ISNI 0000 0001 1486 4131, GRID grid.411178.a, Laboratoire de Biochimie et Génétique Moléculaire, , CHU de Limoges, ; 87000 Limoges, France
                [6 ]ISNI 0000 0000 9336 4276, GRID grid.411162.1, Service Medico-Chirurgical de Pediatrie, , CHU de Poitiers, ; 86000 Poitiers, France
                [7 ]ISNI 0000 0000 9336 4276, GRID grid.411162.1, Service de Chirurgie Cardio-Thoracique, , CHU de Poitiers, ; 86000 Poitiers, France
                [8 ]ISNI 0000 0000 9336 4276, GRID grid.411162.1, Service de Néphrologie et Transplantation, , CHU de Poitiers, ; 86000 Poitiers, France
                [9 ]ISNI 0000 0001 2069 7798, GRID grid.5342.0, UGCT-Department of Physics and Astronomy, Faculty of Sciences, , Ghent University, ; Proeftuinstraat 86, 9000 Ghent, Belgium
                [10 ]ISNI 0000 0000 9336 4276, GRID grid.411162.1, Service de Biochimie, , CHU de Poitiers, ; Poitiers, 86000 France
                [11 ]IBiSA ‘Plate-Forme MOdélisation Préclinique-Innovations Chirurgicale et Technologique (MOPICT)’, Domaine Expérimental du Magneraud, 17700 Surgères, France
                [12 ]FHU SUPORT ‘SUrvival oPtimization in ORgan Transplantation’, 86000 Poitiers, France
                Article
                1764
                10.1186/s12967-018-1764-4
                6332834
                30642356
                6a531ca7-782e-4063-8cb0-501262f14ae8
                © The Author(s) 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 2 October 2018
                : 31 December 2018
                Funding
                Funded by: Société de Néphrologie
                Funded by: Fondation Transplantation
                Funded by: Conseil Régional Poitou-Charentes
                Categories
                Research
                Custom metadata
                © The Author(s) 2019

                Medicine
                oxidized ldl,kidney transplantation,vascular remodeling
                Medicine
                oxidized ldl, kidney transplantation, vascular remodeling

                Comments

                Comment on this article